Atelerix
Latest round
- Seed
Last raised
- Jan 2018
Total raised
- $0.6M
Investors
- 4
About Atelerix
Atelerix Ltd.Founded in 2017 in Cambridge, UK, Atelerix Ltd. focuses on developing solutions for cell preservation, avoiding the complexities of cryopreservation. The founders, Che Connon and Stephen Swioklo, have worked on establishing a strong technological foundation to support the needs of their clients.Atelerix specializes in innovative cell preservation technology, leveraging hypothermic gel-based solutions to maintain the viability of live cells, tissues, and viruses during transport. Their core offerings support the shipping of various biological materials including suspended and adherent cells, leukapheresis material, primary tissues, organoids, spheroids, and multi-well plates. This technology eliminates the need for cryopreservation, allowing samples to be safely shipped at room temperature, simplifying logistics and reducing costs for laboratories and research institutions.Atelerix generates revenue through direct sales of its cell preservation products primarily targeting the biotechnology and pharmaceutical sectors. Their business model emphasizes B2B transactions, with clients purchasing products as needed or establishing long-term agreements for regular supply. The pricing structure remains competitive, reflecting the advanced technology and sustainability benefits of their offerings, including specialized preservation kits tailored to specific biological materials. Future initiatives include the development of new products aimed at expanding their product range and entering additional markets. Atelerix intends to target growth in specific geographic regions and aims to solidify its presence in North America and Asia by the end of 2025. The funds will be utilized to bolster marketing strategies and sales operations to support these ambitious expansion plans.
Who invested in Atelerix
4 investors across 1 round
See all investors in Atelerix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 26, 2018
Amount
$0.6M
Investors
Questions about Atelerix
Who invested in Atelerix?
Atelerix has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atelerix raised?
Atelerix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Atelerix last raise money?
Atelerix's most recent round on record is a Seed, in Jan 2018.
What does Atelerix do?
Atelerix is a biotechnology company.
Where is Atelerix headquartered?
Atelerix is headquartered in Cambridge, UK.
Which VCs invest in companies like Atelerix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Atelerix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Atelerix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.